1Life Healthcare, Inc. (ONEM) Reports Q1 Loss, Tops Revenue Estimates

1Life Healthcare, Inc. (ONEM) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 4.08%. A quarter ago, it was expected that this company would post a loss of $0.49 per share when it actually produced a loss of $0.50, delivering a surprise of -2.04%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

1Life Healthcare, Inc., which belongs to the Zacks Medical Info Systems industry, posted revenues of $254.1 million for the quarter ended March 2022, surpassing the Zacks Consensus Estimate by 2.71%. This compares to year-ago revenues of $121.35 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

1Life Healthcare, Inc. Shares have lost about 57.8% since the beginning of the year versus the S&P 500's decline of -12.4%.

What's Next for 1Life Healthcare, Inc.

While 1Life Healthcare, Inc. Has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?